• About ARCA
  • Our Science
  • Clinical Trials
  • Collaborations
  • Investors
  • Contact Us

ARCA Biopharma Precision Medicine

  • About ARCA
  • Our Science
  • Clinical Trials
  • Collaborations
  • Investors
  • Contact Us

ARCA Biopharma Precision Medicine

  • About ARCA
  • Our Science
  • Clinical Trials
  • Collaborations
  • Investors
  • Contact Us

Slider 4

Recent Posts

  • JACOB MA-WEAVER JOINS ARCA BIOPHARMA BOARD OF DIRECTORS
  • ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
  • ARCA biopharma Announces First Quarter 2022 Financial Results
  • ARCA biopharma Establishes Special Committee of the Board of Directors
  • ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2B Clinical Trial

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • May 2021
  • March 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • February 2020
  • November 2019
  • September 2019
  • August 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • December 2018
  • November 2018
  • September 2018
  • August 2018
  • July 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • November 2016
  • October 2016
  • August 2016
  • May 2016
  • April 2016
  • March 2016
  • January 2016
  • November 2015
  • September 2015
  • August 2015
  • June 2015

Categories

  • Press Release
  • Uncategorized
ARCA Biopharma Logo
  • 720-940-2100
  • 10170 Church Ranch Way, Suite 100
  • Westminster, CO 80021
  • About ARCA
  • Our Science
Slash
  • Clinical Trials
  • Collaborations
Slash
  • Investors
  • Contact
    • © 2022 ARCA Biopharma.

    • Slash
      • Sitemap
      • Legal Disclaimer
Designed by Watermark